跳至主要内容
临床试验/JPRN-jRCT1080222009
JPRN-jRCT1080222009未知4 期

Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom: a Randomised Placebo-controlled Study

Eisai Co., Ltd.0 个研究点目标入组 48 人开始时间: 2013年1月24日最近更新:
适应症

试验速览

阶段
4 期
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized Intervention Model:Cross-over Masking: Double Blind (Subject, Investigator)

入排标准

年龄范围
>= 20age old 至 <= 84age old(—)
性别
All

入选标准

  • Diagnosis of COPD
  • Forced expiratory volume in 1 second (FEV1) of <80% of the predicted value
  • Ratio of FEV1 to forced vital capacity (FVC) of <70%
  • Symptom of expectorated sputum
  • Brinkman index 200 or more
  • Smoking history
  • For Asthma:
  • Diagnosed partly controlled by global initiative for asthma
  • Symptom of expectorated sputum
  • Scored between 20 to 24 by ACT (Asthma Control Test)

排除标准

  • Patients with egg allergy
  • Patients with domiciliary oxygen therapy
  • Patients with pneumonia or pulmonary tuberculosis
  • Patients with severe cardiovascular disorder, severe kidney disorder, severe hepatic disorder, severe hematological disorder
  • Patients with cancer

研究者

相似试验